Thursday / May 22. 2025
menu-logo menu-logo
brand-logo
Subscribe
Subscribe
Thursday / May 22. 2025
  • Read
    • Daily News
      • Financial
      • Insights
      • U.S.
      • International
    • Digital Issue
    • Executive Announcements
    • Cover Stories
    • Feature Articles
      • Exclusive Interviews
    • International Focus
    • Company Spotlights
    • Forward Thinking
    • Legal Briefs
    • Insights from the Outside
    • For You | For Your Field
    • Working Smart
  • Listen & Watch
    • Direct Approach Podcast
    • SHIFT podcast
    • The DSN Podcast
  • Attend
    • DSU Europe 2025
    • DSU Fall 2025
  • Achieve
    • Global 100 List
    • Bravo Awards
    • Best Places to Work
    • Legends
  • Research
    • Stock Watch
    • The DSN Guide
    • Supplier Directory
    • Stock Ticker
    • Resources
  • Engage
    • Supporter Program
    • VIP Text Alerts
  • About
    • About DSN
    • Subscribe
    • Advertise
    • Connect
  • Search
Subscribe

Medifast, OPTAVIA See Record Growth in 2017

BY DSN Staff | March 07, 2018 | read / Daily News / Financial

Medifast, Inc., a Owings Mills, Maryland-based  manufacturer and distributor of clinically proven, healthy living products and programs, yesterday reported financial results for the fourth quarter and full year ended December 31, 2017.

“Our financial results exceeded our expectations and we are pleased to report a strong finish to the year with revenue through our OPTAVIA Coaches model generating record growth,” said Dan Chard, Medifast’s CEO. “Looking ahead, our OPTAVIA coach community is now stronger than ever and very well-positioned to build upon the current business momentum as they share our mission of offering the world lifelong transformation, one healthy habit at a time.”

For the fourth quarter of 2017, Medifast revenue increased 24.8 percent to $78.0 million from revenue of $62.5 million for the fourth quarter last year.

OPTAVIA revenue increased 32.4 percent to $68.6 million in the fourth quarter of 2017, compared to $51.8 million for the fourth quarter last year. This is the ninth consecutive quarter of growth. The total number of active earning OPTAVIA Coaches for the fourth quarter of 2017 increased to 15,000, compared to 12,500 for the fourth quarter of 2016. The average revenue per active earning OPTAVIA Coach for the fourth quarter of 2017 increased 9.7 percent to $4,562 compared to $4,158 for the fourth quarter last year.

Medifast Direct revenue decreased 2.9 percent to $6.6 million in the fourth quarter of 2017, compared to $6.8 million for the fourth quarter of 2016. Fourth quarter advertising spend decreased $0.1 million from $1.6 million for the fourth quarter last year.

Revenue in the Franchise Medifast Weight Control Centers decreased to $2.6 million from $3.6 million for the fourth quarter of last year. The decrease in revenue was primarily driven by fewer franchise centers in operation during the period combined with a decline in activity within the centers and a decrease in resellers. The company ended the quarter with 16 franchise centers and 18 reseller locations in operation compared to 37 franchise centers and 19 reseller locations at the end of the same period last year.

In the fourth quarter, the Wholesale business unit revenue was consistent with the prior year period at $0.2 million. This business model was integrated into the OPTAVIA coach model at year end.

For the fiscal year ended December 31, 2017, Medifast revenue was $301.6 million as compared to revenue of $274.5 million in 2016. As a percentage of revenue, OPTAVIA represented approximately 85.1 percent, Medifast Direct represented 10.6 percent, Franchise Medifast Weight Control Centers represented 4.0 percent, and Medifast Wholesale represented 0.3 percent.

The company expects first quarter revenue to be in the range of $88.5 million to $91.5 million and earnings per diluted share to be in the range of $0.84 to $0.87. For the full year 2018, the company expects revenue of $350 million to $360 million and earnings per diluted share of $3.15 to $3.25.

To read the full Medifast fourth quarter report, click here.

Posted in Daily News, Financial and tagged Coach, Dan Chard, Direct Selling, DSN, Maryland, Medifast, Medifast Direct, MLM, Multi-Level Marketing, OPTAVIA, Owings Mills, Weight Control Center, Wholesale.
Related Articles
Natura &Co Reports Q1 2025 Financial Results May 20, 2025

Natura &Co Reports Q1 2025 Financial Results

Read more
Mannatech Reports Q1 2025 Financials May 19, 2025

Mannatech Reports Q1 2025 Financials

Read more
BODi Reports Q1 Financial Results for 2025 May 16, 2025

BODi Reports Q1 Financial Results for 2025

Read more
brand-logo
The News You Need.
The Name You Trust.
Subscribe

Breaking global news, emerging trends and powerful stories conveniently curated to help direct selling executives stay informed, engaged and a step ahead.

  • Read
  • Listen & Watch
  • Attend
  • Achieve
  • Research
  • About
  • Connect
5717 Legacy Drive
Suite 250
Plano, Texas 75024
info@directsellingnews.com
Copyright 2025 Direct Selling News | All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Advertise
  • Subscribe
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT